Population pharmacokinetics of gentamicin in horses.

The research was conducted to create and validate a model to understand how the antibiotic gentamicin performs inside the body of horses, using past clinical data. In the study, factors like body weight and serum creatinine concentration were discovered to explain significant variance in gentamicin behavior in individual horses.

Methodology

• The research utilized historical clinical data from the treatment of 62 horses that had received multiple intravenous doses of gentamicin from 1987 to 1996 at a veterinary teaching hospital.
• Out of these, 46 horses comprised the study group while the remaining 16 were kept for validation purposes.
• Key data, including dosage details, sample collection times, and selected pathophysiological variables were recorded for each individual horse.
• The researchers analyzed these samples with a technique called fluorescence polarization immunoassay.
• A pharmacostatistical analysis was conducted with the help of computer software and a predictive model was built to link pharmacokinetic parameters with simultaneous pathophysiological variables and estimate both the inter and intraindividual variability.

Results

• They discovered that a two-compartment model best described the data obtained.
• The study found that clearance (CI) was directly correlated to both body weight and serum creatinine concentration (a marker indicating kidney function).
• Volume of the central compartment (Vd(c)) was found to be linearly related to the body weight of horses.
• Interindividual coefficients of variability for clearance and volume of the central compartment were 24 and 16% respectively, highlighting some degree of variance in gentamicin clearance and storage among different horses.
• The residual variability (intraindividual) was found to be 13% and the average prediction error was reported to be 2% with mean absolute prediction error percentage standing at 29%.

Conclusions

• The analysis indicates that population pharmacokinetics, which is the study of the variability in drug exposure among individuals in a population, allows for the examination of the fundamental features of gentamicin distribution in horses even with limited data per individual.
• The study reflects a significant part of the variability in gentamicin behavior can be understood via differences in body weight and serum creatinine concentration.
• The conclusion underscores that population pharmacokinetic models could be used to design first-dosage regimes according to clinical characteristics of individual animals.
• The report also suggests that these models might be incorporated into Bayesian forecasting strategies to enhance plasma concentration predictions in individual patients.